Brain Cancer Immunotherapy Treatment Trail Comes Into Picture

A new trial has been started to patients who recently developed glioblastoma which is a fast moving and aggressive type of brain tumor. 


brain cancer immunotherapy


In order to treat such a medical ailment, a new clinical trial is being developed. As per the information, the trail will be carried out at as many as 15 sites across the United States and China.


Brain Cancer Immunotherapy Treatment Trail 

The aim of this type of trail will be basically to examine if immunotherapy brain cancer vaccine named SurVaxM improves clinical outcomes, especially when added to the standard-of-care chemotherapy Temodar (temozolomide). Researchers expect to enroll 265 patients who will be randomized in the trial.

This is what Abad stated in a press release, “For years, we’ve struggled to move the needle as far as good treatment options for glioblastoma. Our hope is that SurVaxM will offer patients both longer survival and better quality of life,” he said.

“To hopefully be on the precipice of meaningful progress against glioblastoma and to be able to possibly see my patients outside of the hospital — years after their diagnosis — would be incredible.” he added.

Along with receiving SurVaxM in their trail phase, they are also expected to receive montanide as well. It's basically an oil based substance or formulation that comes forward helping the patient's own immune system to recognize the drug.

It further came to light that researches also intended to give such patients with a 2nd injection of Leukine (sargramostim). It's basically a bone marrow simulant that helps to boost patient’s immune system at the first injection site.

As per the primary goal of giving such a treatment option to patients is comparing the effects of SurVaxM on overall survival rate. There are some secondary goals as well that are meant to track the number of grade 3nd 4 (severe and life-threatening) side effects, progression-free survival (PFS; time until disease progresses), as well as overall survival and PFS rates at specified time points.

SurVaxM is becoming quite popular offering treatment against such diseases. It was first developed by Dr. Robert Fenstermaker, Neurosurgery and Michael Ciesielski, assistant professor of Oncology. The same medicine is now being developed by MimiVax, a Buffalo. It's basically a New York-based pharmaceutical company.

The above vaccine basically works by targeting survivin. It's a type of protein that helps cancer cells persist.

This is what Fenstermaker stated, “Glioblastoma is a notoriously aggressive and hard-to-treat cancer. We are encouraged by the results from our earlier studies and excited to bring this treatment option to more brain cancer patients at more centers,” he said.

The above line of treatment has already been proved fruitful in a phase 2 study of 63 patients. They had up to 93.7% survival rate one year after diagnosis as compared to 66% survival rates in some other historical studies conducted earlier.

The brain cancer immunotherapy treatment trail is expected to be completed by April 2024. Researchers hope that this line of treatment is certainly going advantageous to hundreds of such patients.



Also Read: New Study Says COVID-19 Vaccines Are Safe for Cancer Patients



Comments

Post a Comment

Popular posts from this blog

Top 2 Reasons of Development of Asbestos Cancer

Image
Asbestos Cancer happens to be the most devastating form of lung cancer. But do you know how it develops and the probable causes responsible to spread the dreaded ailment? Well, let's give you some insights about this form of cancer before proceeding further. Medical researches had  already   begun as early as 1935 to track down the most common causes related to the Asbestos cancer. After a series of extensive research, the factors responsible to spread this form of cancer was none other than asbestos exposure to your body.  During the research, it was established by the National Cancer Institute that the level of asbestos exposure should be minimized to check the disorder under control. So, more will be the asbestos exposure to your body, lesser time it will take to spread the ailment. In the year 1986, OSHA (Occupational Safety and Health Administration) confirmed without proclaiming any doubts that Americans who have to work with Asbestos are most prone to suffer Lung
Read more

New York Mesothelioma Victims Center Urges A Plumber With Mesothelioma to Call Attorney Erik Karst for Compensation

Image
In the recent past, New York Mesothelioma Victims Center had stated that if anyone is diagnosed with mesothelioma anywhere in the New York city, he will be able to call the attorney Erik Karst to commence a fair compensation process. It's quite simple to approaching a mesothelioma law firm to get the required compensation. In its message to the general public, the mesothelioma center has urged people not to worry about the cost and just call the attorney on a given number so as to sue the company responsible in such cases and a proper investigation could be started. This is what the original statement says, "If you are a current of former plumber who has just been diagnosed with mesothelioma anywhere in New York State or their immediate family please call attorney Erik Karst of the law firm of Karst von Oiste anytime at 800-714-0303 for a no obligation compensation analysis from one of the nation's top mesothelioma attorneys as well as an in-depth explanation of how the
Read more

Top Reasons Why Military Personnel Become Easy Target of Mesothelioma

Image
Mesothelioma is basically a type of lung cancer that occurs mainly due to the asbestos exposure over a period of several years or decades. It develops quite slowly and steadily. The reason why it is a severe type of cancer is because of the fact that it takes the linings and tissues of the coverings of internal organs called mesothelium. And so, it mainly attacks on the linings of lungs and the rest of the abdomen. Due to the severity of mesothelioma, almost 3,000 people are diagnosed with this form of lung cancer every year. There are treatments available that can only alleviate the symptoms to some extent. But there is no complete cure available to recover a patient. In most cases, the victims of mesothelioma are known to have a life expectancy between 19-31 months. With the onset of new and advanced treatment, the survival rate can be increased. Even then, the survival rate in such patients has been found to be quite low due to the severity of the disease. Patients with mesothe
Read more